---
$id: https://graph.org.ai/products/commodity/51182428
$type: Product
source: UNSPSC
code: "51182428"
title: "Denosumab"
class: "51182400"
classTitle: "Calcium regulators and calcium salts"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Denosumab

**UNSPSC Code**: 51182428
**Class**: [Calcium regulators and calcium salts](Calcium regulators and calcium salts.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoclonal antibody with the molecular formula C6404H9912N1724O2004S50, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4EQZ6YO2HI, more generally known as denosumab. European Medicines Agency schedules denosumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB29173. The term DENOSUMAB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, no. 3, 2006, list 56. Most nations schedule Denosumab under HS 30021020 and SITC 54163. SMILES:. As of Q4 2014, DENOSUMAB remains the US FDA Preferred Term for this commodity. . Denosumab bears US NLM identifiers UMLS ID C1690432 and NCI Concept Code C61313.

